Background
Integrase strand transfer inhibitors (INSTIs) are linked to neuropsychiatric adverse events (NPS). This study aimed to evaluate changes in NPS in antiretroviral therapy (ART)-naïve people living with HIV (PWH) who reported baseline NPS symptoms and initiated treatment with either Dolutegravir (DTG) or Darunavir/Cobicistat (DRV/c), both combined with Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC).
Methods
A randomized, open-label clinical trial was conducted at the Hospital de Infectología, Centro Médico Nacional “La Raza” from June 2023 to December 2024 (ClinicalTrials.gov Identifier: NCT06787976). The study assessed changes in NPS scales for depression, anxiety, insomnia, and sleep quality in PWH starting ART with either DTG or DRV/c, both paired with TDF/FTC. All participants underwent psychiatric evaluation before initiating ART. Discontinuation was considered if patients experienced exacerbation of NPS symptoms associated with adverse events by DAIDS grade ≥2. NPS scores were compared at baseline, 12 and 24 weeks.
Results
The study enrolled 55 male patients, with 27 (49.1%) assigned to DRV/c and 28 (50.9%) to DTG. The median age was 26 years (IQR 23-29), baseline CD4+ count was 303 cells/µL (IQR 171-485), and baseline HIV-1 RNA was 4.4 log10 copies/mL (IQR 3.9-4.9) (Table 1). Before ART initiation, 14 patients (25.5%) reported suicidal thoughts. In the DTG group, 8 patients (28.6%) discontinued ART due to new-onset suicidality and worsening NPS symptoms. Both groups showed significant reductions in NPS scores at 12 weeks compared to baseline. No significant differences were found in the scales (Table 2). During the 12-week period, 17 participants (60.7%) in the DTG group required antidepressant treatment, compared to 5 (18.5%) in the DRV/c group (p=0.110). DTG was associated with a higher risk of ART discontinuation (RR 4.3, 95% CI 1.00-18, p=0.026) and the need for psychiatric intervention (RR 2.4, 95% CI 1.09-5.37, p=0.019). Risk factors are detailed in Table 2. The study was terminated early for ethical reasons.
Conclusions
DTG was linked to higher rates of ART discontinuation due to worsening NPS, including new-onset suicidality and greater need for psychiatric intervention, such as antidepressants. The study was terminated early for ethical reasons due to these adverse outcomes in the DTG arm.